Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7934 results

Sort By:

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Study ID: NCT06860880
Start Date: 2025-06
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Exercise

Diet

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Infusion System for Hepatic Cancer

Study ID: NCT04684862
Start Date: 2021-02-08
End Date: 2029-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Medtronic SynchroMed II programmable pump connected to an Intera tapered catheter (Combined Infusion System)

Sponsor

Ronald Dematteo, M.D.

Source: clinicaltrials.gov

Share:
Add to list

TOP 2301: Neoadjuvant Chemo for NSCLC

Study ID: NCT06385262
Start Date: 2025-03-17
End Date: 2029-10-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

126

Intervention / Treatment

Alrogakebab

Cemiplimab

Chemotherapy

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Study ID: NCT06876662
Start Date: 2025-05
End Date: 2032-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

279

Intervention / Treatment

Pester

Sponsor

Eli Lilly and Company

Source: clinicaltrials.gov

Share:
Add to list

Lung EpiCheck Biomarkers Development Study

Study ID: NCT06245876
Start Date: 2022-05-17
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

6000

Intervention / Treatment

Blood collection

Sponsor

Nucleix Ltd.

Source: clinicaltrials.gov

Share:
Add to list

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Study ID: NCT06273176
Start Date: 2023-01-01
End Date: 2028-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

225

Intervention / Treatment

Awake mapping under local anesthesia

Asleep mapping under general anesthesia

Resection under general anesthesia without mapping

Sponsor

Erasmus Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane

Study ID: NCT03930680
Start Date: 2021-09-14
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

25

Intervention / Treatment

Dexrazoxane

Sponsor

University of Arkansas

Source: clinicaltrials.gov

Share:
Add to list

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

Study ID: NCT05156060
Start Date: 2022-01-24
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

64

Intervention / Treatment

Gabapentin

Ketamine

Sponsor

Natalie Lockney

Source: clinicaltrials.gov

Share:
Add to list

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

Study ID: NCT03260491
Start Date: 2017-10-30
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

309

Intervention / Treatment

HER3-DXd (FL-DP)

HER3-DXd (CTM-1 Lyo-DP)

HER3-DXd (CTM-3 Lyo-DP)

Sponsor

First mountain

Source: clinicaltrials.gov

Share:
Add to list

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Study ID: NCT03520491
Start Date: 2018-04-25
End Date: 2026-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Nivolumab

Ipilimumab

Radical cystectomy

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list